78 results
Page 2 of 4
8-K
EX-99.1
lgxh7l
2 Nov 20
DURECT Corporation Appoints Dr. Norman Sussman as Chief Medical Officer
4:16pm
8-K
EX-99.1
6uqf0a pv36
2 Nov 20
DURECT Corporation Announces Third Quarter 2020 Financial Results and Update of Programs
12:00am
8-K
EX-99.1
6vnk99s b26rlgm8y
5 Oct 20
Other Events
9:00am
8-K
EX-99.1
lybc0oy8nip88n8n0
23 Sep 20
Other Events
9:01am
8-K
EX-99.1
pyfracfs
22 Sep 20
Other Events
9:00am
8-K
EX-99.1
ov3ux 7so2917
27 Aug 20
Other Events
8:45am
8-K
EX-99.1
92o5ftp
3 Aug 20
DURECT Corporation Announces Second Quarter 2020 Financial Results and Update of Programs
4:21pm
8-K
EX-99.1
kp5779 vajloay5x3
1 Jul 20
Other Events
9:01am
8-K
EX-99.1
iurqxfdghilelqj315g
29 Jun 20
DURECT Corporation Joins the Russell 3000® Index
10:00am
8-K
EX-99.1
gvtd7vtma30ivghym
26 Jun 20
Gilead Terminates License Agreement for Long-Acting Injectable HIV Investigational Product
5:20pm
8-K
EX-99.1
66h3v7wiav5zowdb
26 May 20
DURECT Corporation Announces Positive Topline Data from Phase 1b Study of DUR-928 in NASH
9:00am
8-K
EX-99.1
dlj7vckdq00c4a
11 May 20
DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs
4:15pm
8-K
EX-99.1
ewy8colgq13jptgiznt
3 Mar 20
DURECT Corporation Announces Fourth Quarter and Full Year 2019 Financial Results and Update of Programs
4:15pm
8-K
EX-99.1
kpc8 d4kltzsj
4 Nov 19
DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs
4:15pm